To determine whether the leptin receptor and STAT3 signaling are involved in the leptin-induced upregulation of MTA1 expression, both breast cancer cell lines were treated with a leptin receptor blocker (Ob-R BP) and a STAT3 inhibitor (AG490). Here, MTA1 is linked to breast cancer.